You just read:

Forge Therapeutics Receives Notice Of Allowance From U.S. Patent And Trademark Office Covering Novel Chemistry Targeting LpxC For The Treatment Of Gram-Negative Bacterial Infections

News provided by

Forge Therapeutics, Inc.

Aug 14, 2019, 08:00 ET